Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,445,400
-$17,471,212 QoQ
Shares Held
90,000
-55.3% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#123
of 1,038 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $396,101,149 across 12 Drug Manufacturers - General names. BIIB ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
100,000 | $119,943,010 | |
| 2 | AMGN |
Amgen Inc
|
281,000 | $101,755,720 | |
| 3 | ABBV |
AbbVie Inc.
|
402,440 | $101,270,001 | |
| 4 | NVO |
Novo Nordisk A S
|
730,000 | $34,996,200 | |
| 5 | BIIB |
Biogen Inc.
This page
|
90,000 | $19,445,400 | |
| 6 | PFE |
Pfizer Inc
|
435,000 | $10,474,800 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
56,540 | $3,257,834 | |
| 8 | GRFS |
Grifols SA
|
435,361 | $3,082,355 |
All Filings in BIIB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,445,400 | 90,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,916,612 | 201,367 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $39,045,141 | 221,860 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $35,461,392 | 253,151 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $33,625,466 | 267,740 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $27,439,156 | 200,520 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $36,854,943 | 241,008 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $58,152,000 | 300,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $45,204,900 | 195,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $48,516,750 | 225,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $34,933,950 | 135,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $21,203,325 | 82,500 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,378,875 | 57,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,390,347 | 109,306 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,538,300 | 52,500 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $12,682,500 | 47,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,098,500 | 25,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,159,000 | 15,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,556,480 | 44,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,659,800 | 20,000 | Shares | Sole | 2021-12-29 | |
| 2021-06-30 | $5,194,050 | 15,000 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $4,897,200 | 20,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $14,184,000 | 50,000 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $12,708,625 | 47,500 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,163,800 | 10,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||